Bon Natural Life Limited. (NASDAQ:BON) Q4 2022 Earnings Conference Call February 10, 2023 9:00 AM ET Company Participants Unidentified Company Representative - Investor Relations Richard Hu - Chairman and Chief Executive Officer Zhenchao Li - Chief Financial Officer Yingchun Xue - COO Wenjuan Chen - CMO Conference Call Participants Operator Good day and welcome to the Bon Natural Life Fiscal Year 2022 Limited Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions]. Pl ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ OR ☐ SHELL COMPANY REPORT PURSUAN ...

Summary of Bon Natural Life Limited H2 2022 Earnings Conference Call Company Overview - **Company Name**: Bon Natural Life Limited (NASDAQ: BON) - **Industry**: Natural health and personal care, focusing on bioingredient solutions - **Product Categories**: - Fragrance compounds - Health supplements - Bioactive food ingredients - **Key Clients**: Includes major names in Asia and the US/Europe such as International Flavors & Fragrances, Mars Wrigley, and Angel Yeast [3][4] Core Financial Performance - **Revenue**: Approximately $13.7 million for H1 2022, a 17% increase year-over-year [10] - **Gross Profit**: Approximately $4 million, up 19.6% [11] - **Net Income**: Increased from $2.3 million to $2.5 million, a 10.2% rise [12] - **Diluted Earnings Per Share**: $0.30 compared to $0.40 in the same period of 2021 [12] Product Category Performance - **Fragrance Compounds**: Revenue increased by 24.9% from $6 million to $7.4 million, driven by higher average selling prices [12][13] - **Health Supplements**: Revenue decreased by 28.5% from $4.7 million to $3.3 million due to raw material shortages and logistics disruptions [13][14] - **Bioactive Food Ingredients**: Revenue surged by 171.8% from $1.1 million to $2.9 million, attributed to volume growth and higher selling prices [14] Manufacturing and Capacity Expansion - **Yumen Plant**: Construction completed, expected to commence production in September 2022. The plant aims to increase production capacity for fragrance compounds and bioactive food ingredients by 200%, with a projected 150% annualized revenue growth potential [5][24] - **New Product Development**: Introduction of innovative products such as FeatherPure and a broccoli-based probiotic drink, expected to generate approximately $3 million in revenue over two years [6][7] Market Strategy and Growth Outlook - **Domestic vs. International Sales**: Domestic sales accounted for approximately 95.7% of total revenue, with a 22.4% increase. International sales were limited to about $600,000 due to COVID-19 logistics disruptions [15] - **Future Growth Strategies**: Plans to expand product lines, develop new products targeting various health aspects, and pursue mergers and acquisitions to enhance capabilities [8][9] Key Challenges and Considerations - **Supply Chain Issues**: Ongoing challenges due to global supply chain disruptions and inflation affecting raw material costs [21] - **Market Conditions**: The company remains optimistic about maintaining growth despite slower rates compared to previous years due to external factors [22] Additional Insights - **Government Support**: Received approximately $542,000 in government subsidies, indicating continued support for high-tech companies [12] - **Management Confidence**: Leadership expressed confidence in R&D capabilities and business strategies to capture market share and sustain growth momentum [17] This summary encapsulates the key points from the earnings conference call, highlighting the company's performance, strategic initiatives, and market outlook.

Bon Natural Life Limited (NASDAQ:BON) FY2021 Earnings Conference Call February 3, 2022 9:00 AM ET Company Participants Richard Hu – Chairman and CEO Zhenchao Li – Chief Financial Officer Maggie Zhang – Investor Relations Conference Call Participants Brian Hartzband – H4H Operator Good day and welcome to the Bon Natural Life Limited 2021 Full Year Financial Earnings Conference Call. All participants will be on listen-only mode. For those on the phone, there will be an opportunity to ask questions. [Operator ...